TerminatedNot Applicable

Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention

Stopped: Data difficult to collect due to the COVID-19 pandemic.

United States22 participantsStarted 2018-12-10

Plain-language summary

This study evaluates a Decision Aid to help patients with de Quervain's tenosynovitis decide how to treat their condition. For patients with symptoms of depression, half the participants will receive a psychological intervention (Toolkit) to improve depression and pain from de Quervain's tenosynovitis. The investigators hypothesize that both the Decision Aid and the Toolkit will be feasible, and that the Toolkit will improve pain and function compared to usual care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (≥18 years) diagnosed with de Quervain's tenosynovitis * English fluency and literacy * Ability to give informed consent Exclusion Criteria: * Inability or unwillingness to participate in decision aid (DA) and/or Toolkit-depression * Major medical comorbidity expected to worsen in the next 6 months * Comorbid chronic pain condition * Antidepressant medications changes in the past 6 months * Severe and untreated mental health conditions or active substance dependence * Secondary gains such as litigations or worker compensation procedures that may interfere with patients' motivation for treatment * No online device available to use the DA and Toolkit-depression

What they're measuring

QuickDASH score (Disabilities of the Arm Shoulder and Hand)

Timeframe: 6 months

Numerical Pain Rating Scale

Timeframe: 6 months

Trial details

NCT IDNCT04069741

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-19

View on ClinicalTrials.gov More De Quervain Disease trials